Hawkins, Inc. HWKN logged earnings of 72 cents per share in the third quarter of fiscal 2025 (ended Dec. 29, 2024), up from 71 cents in the year-ago quarter. Earnings in the reported quarter missed the Zacks Consensus Estimate of 78 cents.
Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
The company registered revenues of $226.2 million for the quarter, up around 8% year over year. It beat the Zacks Consensus Estimate of $219.2 million. Higher sales in the Water Treatment unit more than offset the decline in the Industrial segment.
Hawkins, Inc. price-consensus-eps-surprise-chart | Hawkins, Inc. Quote
Sales from the Water Treatment segment climbed 22% year over year to $99.8 million. Sales were driven by added sales from acquired businesses and higher sales volumes in the legacy business. The segment benefited from the seven acquisitions that HWKN completed over the past 18 months.
Industrial segment sales fell 1% year over year to $92 million in the reported quarter. Sales in the segment were affected by reduced selling prices on certain products due to lower raw material costs and product mix changes.
Health and Nutrition segment sales increased 3% year over year to $34.5 million. The upside was driven by higher sales of manufactured products.
The company ended the quarter with cash and cash equivalents of roughly $8.3 million, up around 10% sequentially. Long-term debt was roughly $103.9 million at the end of the quarter, up around 11% from the prior quarter.
HWKN generated an operating cash flow of around $80.3 million for the nine months ended Dec. 29, 2024.
Moving ahead, HWKN expects sustained growth in the Water Treatment and Health and Nutrition segments. It expects the Industrial segment to perform similar to the first nine months of fiscal 2025.
Shares of Hawkins have rallied 89.9% in a year compared with the Zacks Chemicals Specialty industry’s decline of 14.5%.
Image Source: Zacks Investment Research
HWKN currently carries a Zacks Rank #3 (Hold).
Better-ranked stocks in the Basic Materials space are Ingevity Corporation NGVT, ICL Group Ltd ICL and Nutrien Ltd. NTR. While NGVT carries a Zacks Rank #1 (Strong Buy), ICL and NTR have a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Ingevity is scheduled to release fourth-quarter results on Feb.18. The Zacks Consensus Estimate for NGVT’s fourth-quarter earnings is pegged at 12 cents. NGVT surpassed the Zacks Consensus Estimate in three of the trailing four quarters while missing once. It has a trailing four-quarter earnings surprise of 95.4%, on average.
ICL Group is slated to release fourth-quarter results on Feb.26. The consensus estimate for ICL’s fourth-quarter earnings is pegged at 6 cents. It surpassed the Zacks Consensus Estimate for earnings in each of the last four quarters at an average of 18.1%.
Nutrien is scheduled to release fourth-quarter results on Feb.19. The Zacks Consensus Estimate for NTR’s fourth-quarter earnings is pegged at 33 cents. NTR has gained around 2% in the past year.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ICL Group Ltd. (ICL) : Free Stock Analysis Report
Ingevity Corporation (NGVT) : Free Stock Analysis Report
Hawkins, Inc. (HWKN) : Free Stock Analysis Report
Nutrien Ltd. (NTR) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。